Minimally Invasive Thoracic Surgery

Global Minimally Invasive Thoracic Surgery Market to Reach US$3.6 Billion by 2032

The global market for Minimally Invasive Thoracic Surgery estimated at US$2.1 Billion in the year 2025, is expected to reach US$3.6 Billion by 2032, growing at a CAGR of 7.7% over the analysis period 2025-2032. Lobectomy, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$1.9 Billion by the end of the analysis period. Growth in the Wedge Resection segment is estimated at 7.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$660.8 Million While China is Forecast to Grow at 12.1% CAGR

The Minimally Invasive Thoracic Surgery market in the U.S. is estimated at US$660.8 Million in the year 2025. China, the world`s second largest economy, is forecast to reach a projected market size of US$908.2 Million by the year 2032 trailing a CAGR of 12.1% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 7.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

Global Minimally Invasive Thoracic Surgery Market - Key Trends and Drivers Summarized

How Is Minimally Invasive Thoracic Surgery Changing Patient Outcomes?

Minimally invasive thoracic surgery (MITS) is a medical technique used to diagnose and treat conditions affecting the lungs, esophagus, and chest, using smaller incisions compared to traditional open surgery. This approach offers significant benefits to patients, including reduced postoperative pain, shorter hospital stays, quicker recovery times, and fewer complications. MITS encompasses various procedures, such as video-assisted thoracic surgery (VATS), robotic-assisted thoracic surgery (RATS), and thoracoscopic lobectomy, which are commonly used for lung cancer treatment, esophageal disorders, and other thoracic conditions. The use of MITS has been expanding as advancements in surgical instruments and imaging technologies continue to improve the precision and effectiveness of the procedures. VATS, for instance, employs a small camera called a thoracoscope to visualize the chest cavity, allowing surgeons to perform complex procedures through small incisions. Robotic systems provide greater dexterity and control, enhancing the surgeon`s ability to operate in difficult-to-reach areas of the thoracic cavity.

What Innovations Are Driving the Adoption of Minimally Invasive Thoracic Surgery?

Several technological advancements are facilitating the adoption of minimally invasive thoracic surgery. These include the development of high-definition imaging systems, advanced robotic platforms, and improved surgical instruments. Robotic-assisted surgery has gained popularity due to its enhanced precision and reduced risk of complications. The use of 3D imaging and real-time navigation systems during MITS allows for better visualization of the surgical site, leading to more accurate and less invasive procedures. Additionally, the integration of AI and machine learning in surgical planning and execution is emerging as a significant trend. AI algorithms can analyze patient data to predict surgical outcomes and recommend optimal surgical approaches, further improving the success rates of MITS. The availability of specialized training programs and simulation platforms is also helping surgeons to master minimally invasive techniques, increasing the adoption of these procedures in thoracic surgery.

How Do Market Segments Define the Growth of Minimally Invasive Thoracic Surgery?

Surgery types include VATS and RATS, with VATS being the most widely used due to its cost-effectiveness and established clinical outcomes. Applications of MITS cover a range of thoracic conditions, including lung cancer, esophageal cancer, and pleural effusion. Among these, lung cancer surgery holds the largest market share, driven by the rising incidence of lung cancer worldwide and the increasing preference for less invasive treatment options. End-users of MITS include hospitals, specialty clinics, and ambulatory surgical centers. Hospitals account for the largest share due to the availability of advanced surgical equipment and skilled surgeons. However, ambulatory surgical centers are witnessing growth as patients seek outpatient procedures with shorter recovery times. Geographically, North America and Europe are leading the adoption of MITS, while the Asia-Pacific region is experiencing rapid growth due to increasing healthcare expenditure and improving surgical infrastructure.

What Factors Are Driving the Growth in the Minimally Invasive Thoracic Surgery Market?

The growth in the minimally invasive thoracic surgery market is driven by several factors, including the increasing prevalence of thoracic diseases, advancements in surgical technologies, and a growing preference for less invasive procedures. As awareness of the benefits of MITS continues to rise, more patients and healthcare providers are opting for these procedures over traditional open surgery. Technological innovations, such as robotic-assisted systems and AI-driven surgical planning tools, are further enhancing the precision and safety of minimally invasive techniques. Additionally, the shift towards outpatient surgical procedures and the expansion of specialized training programs for surgeons are contributing to the market`s growth.

SCOPE OF STUDY:

The report analyzes the Minimally Invasive Thoracic Surgery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Lobectomy, Wedge Resection, Pneumonectomy, Other Types)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

• Cardio medical GmbH
• Dextera Surgical Inc.
• Grena Ltd.
• Intuitive Surgical
• LivaNova plc
• Medela Healthcare
• Medtronic plc
• Richard Wolf GmbH
• Sklar Surgical Instruments
• Teleflex Incorporated

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher. Show more